semaglutide and alcohol use disorder People with obesity had fewer heavy drinking days while on (Wegovy), a Danish randomized trial showed. Semaglutide-treated adults also showed greater improvements across multiple secondary alcohol-related and GLP-1 medications: The next big

The initiative reflects a shared healthcare strategy to bridge the pharmaceutical and technology sectors and help advance a digital health ecosystem that empowers patients to build healthy daily habits aligned with clinical guidance for FDA-approved medicines

Common symptoms of gastroparesis include: Persistent nausea and vomiting, particularly of undigested food Early satiety (feeling full after eating only small amounts) Abdominal bloating and discomfort Upper abdominal pain Heartburn or gastro-oesophageal reflux Poor appetite and unintentional weight loss Blood glucose fluctuations in people with diabetes The condition occurs when the vagus nerve , which controls stomach muscle contractions, becomes damaged or stops functioning properly

It also improves the utilization of blood glucose (sugar), which aids in burning carbohydrates for energy rather than storing them as fat, increases leptin sensitivity, which causes your body to preferentially burn body fat for a longer period of time, and changes natural brain chemistry, which directly reduces appetite

The worldwide semaglutide market size is predicted to be worth USD 173.59 million by 2033 from USD 115.72 million in 2025, growing at a CAGR of 5.2% from 2025 to 2033

den Hollander, B

(2024f)